Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Rizatriptan may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for Rizatriptan belongs to a class of medicines called selective serotonin 5-HT1B/1D receptor agonists. Rizatriptan is used to treat the headache phase of the migraine attack in adults. Treatment with Rizatriptan reduces swelling of blood vessels surrounding the brain. This swelling results in the headache pain of a migraine attack.
e Rizatriptan
Do not take Rizatriptan if:
Warnings and precautions Talk to your doctor or pharmacist before taking Rizatriptan, if:
Other medicines and Rizatriptan Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This includes herbal medicines and those you normally take for a migraine. This is because Rizatriptan can affect the way some medicines work. Also, other medicines can affect Rizatriptan. Do not take Rizatriptan if you are taking:
Rizatriptan with food and drink Rizatriptan can take longer to work if it is taken after food. Although it is better to take it on an empty stomach, you can still take it if you have eaten.
Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby ask your doctor or pharmacist for advice before taking this medicine. Available data on the safety of rizatriptan when used during the first 3 months of pregnancy do not suggest an increased risk of birth defects. It is not known whether Rizatriptan is harmful to an unborn baby when taken by a pregnant woman after the first 3 months of pregnancy. If you are breastfeeding, you may postpone breastfeeding for 12 hours after treatment to avoid exposure in your baby.
Driving and using machines You may feel sleepy or dizzy while taking Rizatriptan. If this happens, do not drive or use any tools or machines.
Rizatriptan contains aspartame This medicine contains 1.45mg aspartame in each orodispersible tablet. This medicine contains 2.90mg aspartame in each orodispersible tablet. Aspartame is a source of phenylalanine. It may be harmful if you have phenylketonuria (PKU), a rare genetic disorder in which phenylalanine builds up because the body cannot remove it properly.
Rizatriptan Rizatriptan is used to treat migraine attacks. Take this medicine as soon as possible after your migraine headache has started. Do not use it to prevent attack. Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is 10mg. If you are currently taking propranolol or have kidney or liver problems you should use the 5mg dose of Rizatriptan. You should leave at least 2 hours between taking propranolol and Rizatriptan up to a maximum of 2 doses in a 24-hour period.
Method of administration
If migraine returns within 24 hours In some patients, migraine symptoms can return within a 24-hour period. If your migraine does return, you can take an additional dose of Rizatriptan. You should always wait at least 2 hours between doses.
If after 2 hours you still have migraine If you do not respond to the first dose of Rizatriptan during an attack, you should not take a second dose of Rizatriptan for treatment of the same attack. It is still likely, however, that you will respond to Rizatriptan during the next attack. Do not take more than 2 doses of Rizatriptan in a 24-hour period. You should always wait at least 2 hours between doses. If your condition worsens, seek medical attention.
Use in children and adolescents The use of Rizatriptan in children under 18 years of age is not recommended.
Use in patients older than 65 years There have been no full studies to look at how safe and effective Rizatriptan is amongst patients older than 65 years.
Pharmacodes
rizatriptan
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme (website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store). By reporting side effects you can help provide more information on the safety of this medicine.
Rizatriptan
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine. In studies, the most common side effects reported were dizziness, sleepiness and tiredness. Tell your doctor right away if you have symptoms of allergic reactions, serotonin syndrome, heart attack or stroke (see the list below). In addition, tell your doctor if you experience any symptoms that suggest an allergic reaction (such as a rash or itching) after taking Rizatriptan.
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1000 people
Not known: frequency cannot be estimated from the available data
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and blister after "EXP". The expiry date refers to the last day of the month. Do not store above 30oC. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
What Rizatriptan contains The active substance is rizatriptan. Each Rizatriptan 5mg orodispersible tablet contains 7.265mg of rizatriptan benzoate equivalent to 5mg of rizatriptan. Each Rizatriptan 10mg orodispersible tablet contains 14.53mg of rizatriptan benzoate equivalent to 10mg of rizatriptan. The other ingredients are: microcrystalline cellulose, maize starch, silica colloidal anhydrous, aspartame (E951), mint powder (consisting of mint oil, terpeneless mint oil, eucalyptol, menthone, isomenthone, menthyl acetate, menthol) and magnesium stearate.
What Rizatriptan looks like and contents of the pack 5mg orodispersible tablets are white, round, biconvex tablets with dimensions 7.1±0.1mm and 2.4±0.2mm in thickness. 10mg orodispersible tablets are white, round, biconvex tablets with a score line in one side and dimensions 10.0±0.1mm and 2.9±0.2mm in thickness. Pack sizes: Packs with 2, 3, 6, 12 or 18 orodispersible tablets. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder: Aspire Pharma Ltd Unit 4, Rotherbrook Court Bedford Road Petersfield Hampshire GU32 3QG United Kingdom
Manufacturer: Pharmathen S.A. 6 Dervenakion str. 15351 Pallini Attiki Greece Or Pharmathen International S.A. Industrial Park Sapes Rodopi Prefecture Block No 5 Rodopi 69300 Greece This leaflet was last revised in 01/2025 1010074-P7.2
Pharmacodes
Reporting of side effects
If you take more Rizatriptan than you should, talk to your doctor or pharmacist straight away. Take the medicine pack with you. Signs of overdose can include dizziness, drowsiness, vomiting, fainting and slow heart rate. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Pharmacodes
If you take more Rizatriptan than you should
Rizatriptan 5mg Orodispersible tablet comes as tablet containing 5mg. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Rizatriptan 5mg Orodispersible tablet is rizatriptan.
This leaflet reproduces the patient information leaflet approved for Rizatriptan 5mg Orodispersible tablet, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
Medicines sold in Romania with the same active substance: Cunoscut în România ca
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Romanian medicines in the UK →
Medicines sold in Poland with the same active substance: W Polsce znany jako
⚠ Same active substance, but a different pharmaceutical form (for example a gel instead of a tablet). Not interchangeable — ask a pharmacist.
Same active substance. The strength, the form and whether you need a prescription can differ. Always ask a pharmacist before you switch. Polish medicines in the UK →
Ask anything about Rizatriptan 5mg Orodispersible tablet. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.